International Clinical Trial: A randomized, single-blind, multicenter Phase II clinical trial to evaluate the efficacy and safety of YH01 Injection in patients with unresectable locally advanced or metastatic head and neck malignancies who have failed standard treatment

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133618) titled 'A randomized, single-blind, multicenter Phase II clinical trial to evaluate the efficacy and safety of YH01 Injection in patients with unresectable locally advanced or metastatic head and neck malignancies who have failed standard treatment' on Sept. 29.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

Condition: Locally advanced/metastatic head and neck cancer that can't be removed and hasn't responded to standard treatments

Intervention: Low-Dose group:Intratumoral Injection of YH01(8x10^10 IFU)

Recrui...